AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

96 hedge funds and large institutions have $20.2M invested in Akebia Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 34 reducing their positions, and 49 closing their positions.

Holders
96
Holders Change
-28
Holders Change %
-22.58%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
17
Reduced
34
Closed
49
Calls
$212K
Puts
$65K
Net Calls
+$147K
Net Calls Change
-$1.57M

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$2.59M
2
Millennium Management
2
Millennium Management
New York
$1.89M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.74M
4
HF
4
HRT Financial
New York
$389K
5
E
5
Ergoteles
New York
$300K

Top Sellers

1
State Street
1
State Street
Massachusetts
$203K
2
BlackRock
2
BlackRock
New York
$1.53M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$3K
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$276K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$571K
Name Market Value Shares Shares
Change 		Shares
Change %
CG
151
Cutler Group
California
$0 200 +200 New
EI
152
Ellevest Inc
New York
$0 443 +443 New
TC
153
Truvestments Capital
Florida
$0 900 +900 New
3 4 5 6
7